Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,357 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CML-466 Asciminib Provides Durable Molecular Responses in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With the T315I Mutation: Updated Efficacy and Safety Data From a Phase I Trial.
Hughes TP, Cortes JE, Réa D, Mauro MJ, Hochhaus A, Kim DW, Sasaki K, Lang F, Heinrich MC, Breccia M, Deininger M, Goh YT, Janssen JJWM, Talpaz M, Coutre PL, Kapoor S, Cacciatore S, Polydoros F, Agrawal N, Mahon FX. Hughes TP, et al. Among authors: janssen jjwm. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S300. doi: 10.1016/S2152-2650(22)01388-X. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36163936 Clinical Trial.
Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters.
van Gils N, Verhagen HJMP, Broux M, Martiáñez T, Denkers F, Vermue E, Rutten A, Csikós T, Demeyer S, Çil M, Al M, Cools J, Janssen JJWM, Ossenkoppele GJ, Menezes RX, Smit L. van Gils N, et al. Among authors: janssen jjwm. iScience. 2022 Aug 25;25(9):105013. doi: 10.1016/j.isci.2022.105013. eCollection 2022 Sep 16. iScience. 2022. PMID: 36097617 Free PMC article.
1,357 results